Cite
HARVARD Citation
Bagot, M. et al. (n.d.). Lacutamab in patients (pts) with advanced mycosis fungoides (MF) according to KIR3DL2 expression: early results from the TELLOMAK phase 2 trial. European journal of cancer. pp. S20-S21. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bagot, M. et al. (n.d.). Lacutamab in patients (pts) with advanced mycosis fungoides (MF) according to KIR3DL2 expression: early results from the TELLOMAK phase 2 trial. European journal of cancer. pp. S20-S21. [Online].